Search Results - "Ganne‐Carrie, N"

HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis by Nkontchou, G., Ziol, M., Aout, M., Lhabadie, M., Baazia, Y., Mahmoudi, A., Roulot, D., Ganne-Carrie, N., Grando-Lemaire, V., Trinchet, J.-C., Gordien, E., Vicaut, E., Baghad, I., Beaugrand, M.

“…Liver steatosis is a main histopathological feature of Hepatitis C (HCV) infection because of genotype 3. Steatosis and/or mechanisms underlying steatogenesis…”
Get full text

Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol‐related cirrhosis by LEMOINE, M., KATSAHIAN, S., ZIOL, M., NAHON, P., GANNE‐CARRIE, N., KAZEMI, F., GRANDO‐LEMAIRE, V., TRINCHET, J.‐C., BEAUGRAND, M.

“…Summary Background  Hepatic venous pressure gradient (HVPG) is the gold standard for assessing the presence and the severity of portal hypertension (PHT)…”
Get full text

Bone mineral density assessed by dual-energy X-ray absorptiometry in patients with viral or alcoholic compensated cirrhosis. A prospective study by Mahmoudi, A, Sellier, N, Reboul-Marty, J, Chalès, G, Lalatonne, Y, Bourcier, V, Grando, V, Barget, N, Beaugrand, M, Trinchet, J.-C, Ganne-Carrié, N

“…Summary Background/aim Cirrhosis is considered as a risk factor for osteoporosis whose prevalence is poorly known. The aim was to assess prospectively bone…”
Get full text

Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis by Ganne‐Carrie, N, Chastang, C, Chapel, F, Munz, C, Pateron, D, Sibony, M, Deny, P, Trinchet, J, Callard, P, Guettier, C, Beaugrand, M

“…The aim of this study was to identify high‐risk patients for hepatocellular carcinoma (HCC). Among 151 patients with histologically proven cirrhosis…”
Get full text

Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features by MATHURIN, P., BEUZIN, F., LOUVET, A., CARRIÉ‐GANNE, N., BALIAN, A., TRINCHET, J. C., DALSOGLIO, D., PREVOT, S., NAVEAU, S.

“…Summary Background Studies using consecutive liver biopsies constitute an attractive approach to gaining insight into the pathogenesis of alcoholic liver…”
Get full text

Performance of FibroScan® to detect large esophageal varices in chronic liver diseases is improved by a novel spleen-dedicated examination by Stefanescu, H, Cales, P, Fraquelli, M, Ganne-Carrie, N, Rosselli, M, de Ledinghen, V, Festi, D

Get full text

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death by Degos, F, Christidis, C, Ganne-Carrie, N, Farmachidi, J-P, Degott, C, Guettier, C, Trinchet, J-C, Beaugrand, M, Chevret, S

“…BACKGROUND In patients with hepatitis C virus (HCV) infection and cirrhosis, long term outcome and the incidence of hepatocellular carcinoma (HCC) are still…”
Get full text

O112 : HBsAg clearance after addition of 48 weeks of pegifn in HBeAg negative CHB patients on nucleos(T)ide therapy with undetectable hbvdna for at least one year: final results from ANRS-HB06 pegan study: multicenter randomized controlled phase III trial by Bourliere, M, Rabiega, P, Ganne-Carrie, N, Serfaty, L, Marcellin, P, Pouget, N, Guyader, D, Hezode, C, Picon, M, Causse, X, Leroy, V, Bronowicki, J.P, Riachi, G, Rosa, I, Attali, P, Molina, J.M, Bacq, Y, Tran, A, Grangé, J.D, Zoulim, F, Fontaine, H, Bertucci, I, Bouvier-Alias, M, Carrat, F, Benhamou, Y

Get full text

1024 IDENTIFICATION OF SERUM PROTEOGLYCANS AS PROGNOSTIC BIOMARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND ALCOHOLIC CIRRHOSIS by Nault, J.C, Guyot, E, Laguillier, C, Chevret, S, Ganne-Carrie, N, N'Kontchou, G, Beaugrand, M, Seror, O, Trinchet, J.-C, Lasalle, P, Charnaux, N, Delhedde, M, Sutton, A, Nahon, P

Get full text

653 MULTIPOLAR RADIOFREQUENCY ABLATION FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA >5CM IN DIAMETER: TOLERANCE AND RESULTS AT 3 YEARS by Seror, O, Nkontchou, G, Mahmoudi, A, Cao, Q, Charif, I, Ganne Carrie, N, Grando, V, Boucier, V, Trinchet, J.C, Beaugrand, M

Get full text

Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis by Ganne-Carrie, N, Chastang, C, Chapel, F, Munz, C, Pateron, D, Sibony, M, Deny, P, Trinchet, J, Callard, P, Guettier, C, Beaugrand, M

“…The aim of this study was to identify high-risk patients for hepatocellular carcinoma (HCC). Among 151 patients with histologically proven cirrhosis…”
Get full text

Liver iron is predictive of death in alcoholic cirrhosis: a multivariate study of 229 consecutive patients with alcoholic and/or hepatitis C virus cirrhosis: a prospective follow up study by Ganne-Carrié, N, Christidis, C, Chastang, C, Ziol, M, Chapel, F, Imbert-Bismut, F, Trinchet, J-C, Guettier, C, Beaugrand, M

“…BACKGROUND/AIMS A study was undertaken of liver biopsy samples from 229 consecutive patients with alcoholic or hepatitis C virus related cirrhosis who were…”
Get full text

Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis by Boige, V, Castéra, L, de Roux, N, Ganne-Carrié, N, Ducot, B, Pelletier, G, Beaugrand, M, Buffet, C

“…Background: Liver cirrhosis may lead to hepatocellular carcinoma (HCC), regardless of its cause. Genetic and/or environmental factors may modulate the risk of…”
Get full text

Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis - ANRS HC EP07 study by Bonilla, N., Barget, N., Andrieu, M., Roulot, D., Letoumelin, P., Grando, V., Trinchet, J. C., Ganne-Carrié, N., Beaugrand, M., Deny, P., Choppin, J., Guillet, J., Ziol, M.

“…Little is known about the role of specific hepatitis C virus (HCV) CD8+ T cells in liver damage, especially for the progression of fibrosis, during the highly…”
Get full text

446 REDUCED HEPATIC EXPRESSION OF PERFORIN AND GRANZYME B IN PATIENTS WITH HEMOPHAGOCYTIC SYNDROME by Lemoine, M, BenMena, N, Ganne-Carrie, N, Aras, N, Laroche, C, Roulot, D, Stirnemann, J, Fain, O, Ziol, M

Get full text

[740] ASSESSMENT OF LIVER FIBROSIS USING LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH ALCOHOLIC LIVER DISEASE by Nahon, P, Ziol, M, de Ledinghen, V, Douvin, C, Marcellin, P, Ganne-Carrie, N, Trinchet, J.C, Beaugrand, M

Get full text

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections by Mathurin, P, Thibault, V, Kadidja, K, Ganne-Carrié, N, Moussalli, J, El Younsi, M, Di Martino, V, Lunel, F, Charlotte, F, Vidaud, M, Opolon, P, Poynard, T

“…In patients with multiple hepatotropic viral infections (B and C, or B, C and D), the reciprocal influence of each virus remains controversial. The aims of…”
Get full text

[270] PROSPECTIVE INFLUENCE OF HFE GENE MUTATIONS AND LIVER IRON OVERLOAD ON THE RISK OF HEPATOCELLULAR CARCINOMA OCCURRENCE IN PATIENTS WITH ALCOHOLIC OR HCV-RELATED CIRRHOSIS by Nahon, P, Sutton, A, Rufat, P, Thabut, G, Ziol, M, Fagard, R, Schischmanoff, P.O, Vidaud, D, Charnaux, N, Ganne-Carrie, N, Trinchet, J.C, Gattegno, L, Beaugrand, M

Get full text

Effectiveness and cost-effectiveness of antiviral treatment initiation in hepatitis C related decompensated cirrhosis in France by Willmington, C, Ganne-Carrié, N, Roudot-Thoraval, F, Leroy, V, Fontaine, H, Canva-Delcambre, V, Larrey, D, Pol, S, Mathurin, P, Yazdanpanah, Y, Deuffic-Burban, S

Get full text

Determinants of long term survival and recurrence patterns after radiofrequency ablation for hepatocellular carcinoma developed on cirrhosis by Allaire, M, Rekik, S, Mumana, A, Guyot, E, Nkontchou, G, Bourcier, V, Grando, V, Ziol, M, Nahon, P, Ganne-Carrié, N, Seror, O, Nault, J.-C

Get full text